Work

A Phase 2 Study of Talabostat in Patients With Stage IV Melanoma

Year: 2005

Type: article

Source: Journal of Immunotherapy

DOI: 10.1097/01.cji.0000190991.69459.66

Authors: Thomas F Gajewski, David H Lawson, Bruce G Redman, Casey Cunningham, Sanjiv Agarwala, Marc S Ernstoff, Eric J Haltom, Lysa Gregoire, Margaret J Uprichard

Institutions: Winship Cancer Institute, University of Michigan, U-M Rogel Cancer Center, Mary Crowley Cancer Research Center, UPMC Hillman Cancer Center, Dartmouth–Hitchcock Medical Center

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1996339500

FWCI:

Cites:

Cited by: 1

Related to: 10